{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:50:46Z","timestamp":1790545846843,"version":"4.1.0"},"reference-count":72,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-05927"],"award-info":[{"award-number":["RGPIN-2017-05927"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["761020451"],"award-info":[{"award-number":["761020451"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["PJT-175226"],"award-info":[{"award-number":["PJT-175226"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","award":["RGPIN-2017-05927"],"award-info":[{"award-number":["RGPIN-2017-05927"]}],"id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","award":["761020451"],"award-info":[{"award-number":["761020451"]}],"id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","award":["PJT-175226"],"award-info":[{"award-number":["PJT-175226"]}],"id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RGPIN-2017-05927"],"award-info":[{"award-number":["RGPIN-2017-05927"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["761020451"],"award-info":[{"award-number":["761020451"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-175226"],"award-info":[{"award-number":["PJT-175226"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Graduate Enhancement of Tri-Council Stipends (GETS) through the University of Manitoba","award":["RGPIN-2017-05927"],"award-info":[{"award-number":["RGPIN-2017-05927"]}]},{"name":"Graduate Enhancement of Tri-Council Stipends (GETS) through the University of Manitoba","award":["761020451"],"award-info":[{"award-number":["761020451"]}]},{"name":"Graduate Enhancement of Tri-Council Stipends (GETS) through the University of Manitoba","award":["PJT-175226"],"award-info":[{"award-number":["PJT-175226"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>A subset of expressed genes is associated with a broad H3K4me3 (histone H3 trimethylated at lysine 4) domain that extends throughout the gene body. Genes marked in this way in normal cells are involved in cell-identity and tumor-suppressor activities, whereas in cancer cells, genes driving the cancer phenotype (oncogenes) have this feature. Other histone modifications associated with expressed genes that display a broad domain have been less studied. Here, we identified genes with the broadest H3K79me2 (histone H3 dimethylated at lysine 79) domain in human leukemic cell lines representing different forms of leukemia. Taking a bioinformatic approach, we provide evidence that genes with the broadest H3K79me2 domain have known roles in leukemia (e.g., JMJD1C). In the mixed-lineage leukemia cell line MOLM-13, the HOXA9 gene is in a 100 kb broad H3K79me2 domain with other HOXA protein-coding and oncogenic long non-coding RNA genes. The genes in this domain contribute to leukemia. This broad H3K79me2 domain has an unstable chromatin structure, as was evident by enhanced chromatin accessibility throughout. Together, we provide evidence that identification of genes with the broadest H3K79me2 domain will aid in generating a panel of genes in the diagnosis and therapeutic treatment of leukemia in the future.<\/jats:p>","DOI":"10.3390\/cells11182830","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T20:52:25Z","timestamp":1663015945000},"page":"2830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets"],"prefix":"10.3390","volume":"11","author":[{"given":"Prerna","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-0781","authenticated-orcid":false,"given":"Hedieh","family":"Sattarifard","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Fatemiyan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-6717","authenticated-orcid":false,"given":"Ted M.","family":"Lakowski","sequence":"additional","affiliation":[{"name":"College of Pharmacy Pharmaceutical Analysis Laboratory, University of Manitoba, Winnipeg, MB R3E 0V9, Canada"},{"name":"CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Davie","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"},{"name":"CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The Pathogenesis of Mixed-Lineage Leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3343\/alm.2016.36.2.85","article-title":"Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways","volume":"36","author":"Marschalek","year":"2016","journal-title":"Ann. Lab. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ardp.201400449","article-title":"MLL Leukemia and Future Treatment Strategies","volume":"348","author":"Marschalek","year":"2015","journal-title":"Arch. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2008.002436","article-title":"The molecular biology of mixed lineage leukemia","volume":"94","author":"Slany","year":"2009","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Castiglioni, S., Di Fede, E., Bernardelli, C., Lettieri, A., Parodi, C., Grazioli, P., Colombo, E.A., Ancona, S., Milani, D., and Ottaviano, E. (2022). KMT2A: Umbrella Gene for Multiple Diseases. Genes, 13.","DOI":"10.3390\/genes13030514"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Britten, O., Ragusa, D., Tosi, S., and Kamel, Y.M. (2019). MLL-Rearranged Acute Leukemia with t(4;11)(Q21;Q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?. Cells, 8.","DOI":"10.3390\/cells8111341"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1111\/cas.15054","article-title":"Leukemogenesis via aberrant self-renewal by the MLL\/AEP-mediated transcriptional activation system","volume":"112","author":"Yokoyama","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2015.174","article-title":"Role of HOXA9 in leukemia: Dysregulation, cofactors and essential targets","volume":"35","author":"Collins","year":"2015","journal-title":"Oncogene"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/sj.leu.2400768","article-title":"Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)","volume":"11","author":"Matsuo","year":"1997","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0092-8674(03)00114-4","article-title":"Structure of the Catalytic Domain of Human DOT1L, a Non-SET Domain Nucleosomal Histone Methyltransferase Mosomes during the Cell Division (Grewal and Elgin, 2002). A Recent Addition to the Histone Modification Reper-Toire Is Histone H3 Lysine-79 (Lys79) M","volume":"112","author":"Min","year":"2003","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wood, K., Tellier, M., and Murphy, S. (2018). DOT1L and H3K79 Methylation in Transcription and Genomic Stability. Biomolecules, 8.","DOI":"10.3390\/biom8010011"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15592294.2019.1699991","article-title":"DOT1L: A key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment","volume":"15","author":"Sarno","year":"2019","journal-title":"Epigenetics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cell.2014.09.049","article-title":"AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation","volume":"159","author":"Li","year":"2014","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nature21687","article-title":"ENL Links Histone Acetylation to Oncogenic Gene Expression in Acute Myeloid Leukaemia","volume":"543","author":"Wan","year":"2017","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2016.03.015","article-title":"The role of DOT1L in the maintenance of leukemia gene expression","volume":"36","author":"Wang","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 Is Required for Survival in Human MLL-Rearranged Acute Leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wu, A., Zhi, J., Tian, T., Cihan, A., Cevher, M.A., Liu, Z., David, Y., Muir, T.W., Roeder, R.G., and Yu, M. (2021). DOT1L complex regulates transcriptional initiation in human erythroleukemic cells. Proc. Natl. Acad. Sci. USA, 118.","DOI":"10.1073\/pnas.2106148118"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13148-021-01126-1","article-title":"The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes","volume":"13","author":"Beacon","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ng.3385","article-title":"Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes","volume":"47","author":"Chen","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2014.06.027","article-title":"H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency","volume":"158","author":"Benayoun","year":"2014","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, C., Barnon, M.T., Beacon, T.H., Nardocci, G., and Davie, J.R. (2022). The key role of differential broad H3K4me3 and H3K4ac domains in breast cancer. Gene, 826.","DOI":"10.1016\/j.gene.2022.146463"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Belhocine, M., Simonin, M., Flores, J.D.A., Cieslak, A., Manosalva, I., Pradel, L., Smith, C., Mathieu, E.-L., Charbonnier, G., and Martens, J.H. (2021). Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes. Genome Res.","DOI":"10.1101\/gr.266924.120"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI82978","article-title":"MLL-AF9\u2013 and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C","volume":"126","author":"Zhu","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0145-2126(79)90033-X","article-title":"Properties and usefulness of the original K-562 human myelogenous leukemia cell line","volume":"3","author":"Lozzio","year":"1979","journal-title":"Leuk. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00169-7","article-title":"Cytogenetics of the Chronic Myeloid Leukemia-Derived Cell Line K562","volume":"118","author":"Gribble","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(00)00125-9","article-title":"Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization","volume":"25","author":"Naumann","year":"2001","journal-title":"Leuk. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/10428199809050920","article-title":"P53 Gene Mutation in a T-Acute Lymphoblastic Leukemia Cell Line (Loucy) with t(16:20) and 5q-Chromosomal Aberrations","volume":"29","author":"Prokocimer","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-642-66639-1_30","article-title":"Establishment and Characterization of Leukemic T-Cell Lines, B-Cell Lines, and Null-Cell Line: A Progress Report on Surface Antigen Study of Fresh Lymphatic Leukemias in Man","volume":"Volume 20","author":"Minowada","year":"1977","journal-title":"Immunological Diagnosis of Leukemias and Lymphomas"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Aziz, N.A.A., Mokhtar, N.M., Harun, R., Mollah, M.M.H., Rose, I.M., Sagap, I., Tamil, A.M., Ngah, W.Z.W., and Jamal, R. (2016). A 19-Gene expression signature as a predictor of survival in colorectal cancer. BMC Med. Genom., 9.","DOI":"10.1186\/s12920-016-0218-1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jclinpath-2020-206927","article-title":"Protein tyrosine phosphatase receptor type C (PTPRC or CD45)","volume":"74","author":"Ali","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Henderson, H.J., Karanam, B., Samant, R., Vig, K., Singh, S.R., Yates, C., and Bedi, D. (2017). Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189662"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chen, E.Y., Tan, C.M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G.V., Clark, N.R., and Ma\u2019Ayan, A. (2013). Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-128"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2012.08.048","article-title":"Regulation of HOXA9 Activity by Predominant Expression of DACH1 against C\/EBP\u03b1 and GATA-1 in Myeloid Leukemia with MLL-AF9","volume":"426","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26129","DOI":"10.18632\/oncotarget.15387","article-title":"ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia","volume":"8","author":"Germano","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","unstructured":"NCBI (2021, April 23). Genes & Expression. Gene, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/hmg\/ddab277","article-title":"Neuroligin-3 and neuroligin-4X form nanoscopic clusters and regulate growth cone organization and size","volume":"31","author":"Gatford","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2172-3-10","article-title":"The \u03baB transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3\/KRC: A site selection amplification binding study","volume":"3","author":"Allen","year":"2002","journal-title":"BMC Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1038\/s41467-020-20073-8","article-title":"Thymic iNKT single cell analyses unmask the common developmental program of mouse innate T cells","volume":"11","author":"Krovi","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.2006.09.3534","article-title":"Differential Gene Expression Patterns and Interaction Networks in BCR-ABL\u2013Positive and \u2013Negative Adult Acute Lymphoblastic Leukemias","volume":"25","author":"Juric","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16078454.2021.2010330","article-title":"SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia","volume":"27","author":"Lv","year":"2021","journal-title":"Hematology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fphar.2019.00443","article-title":"Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma","volume":"10","author":"Bilal","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","article-title":"Hox genes in hematopoiesis and leukemogenesis","volume":"26","author":"Argiropoulos","year":"2007","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1242\/dev.109785","article-title":"Cellular and molecular insights into Hox protein action","volume":"142","author":"Rezsohazy","year":"2015","journal-title":"Development"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2017.00255","article-title":"microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview","volume":"7","author":"Gabra","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"108244","DOI":"10.1016\/j.abb.2019.108244","article-title":"HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt\/\u03b2-catenin\/PFKP pathway in acute myeloid leukemia cells","volume":"680","author":"Chen","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Tchinda","year":"2008","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mendes, A., and Fahrenkrog, B. (2019). NUP214 in Leukemia: It\u2019s More than Transport. Cells, 8.","DOI":"10.3390\/cells8010076"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.wneu.2022.02.013","article-title":"A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma","volume":"161","author":"Wang","year":"2022","journal-title":"World Neurosurg."},{"key":"ref_53","first-page":"249","article-title":"Knockdown of SOX12 Expression Induced Apoptotic Factors Is Associated with TWIST1 and CTNNB1 Expression in Human Acute Myeloid Leukemia Cells","volume":"10","author":"Dabiri","year":"2021","journal-title":"Int. J. Mol. Cell. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-016-0337-3","article-title":"DNMT3A Mutation Leads to Leukemic Extramedullary Infiltration Mediated by TWIST1","volume":"9","author":"Xu","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1038\/s41598-021-88382-6","article-title":"Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality","volume":"11","author":"Jukonen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s13577-020-00463-2","article-title":"PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5","volume":"34","author":"Xie","year":"2021","journal-title":"Hum. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2009-03-209395","article-title":"Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10\u2013positive leukemias","volume":"114","author":"Lin","year":"2009","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e101564","DOI":"10.15252\/embj.2019101564","article-title":"Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma","volume":"38","author":"Vlaming","year":"2019","journal-title":"EMBO J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/pmic.200400819","article-title":"A mass spectrometric ?Western blot? to evaluate the correlations between histone methylation and histone acetylation","volume":"4","author":"Zhang","year":"2004","journal-title":"PROTEOMICS"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1101\/gr.176487.114","article-title":"Cotranscriptional histone H2B monoubiquitylation is tightly coupled with RNA polymerase II elongation rate","volume":"24","author":"Fuchs","year":"2014","journal-title":"Genome Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1021\/bi00472a002","article-title":"Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription","volume":"29","author":"Davie","year":"1990","journal-title":"Biochemistry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41467-020-20543-z","article-title":"Transcription shapes genome-wide histone acetylation patterns","volume":"12","author":"Martin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"621578","DOI":"10.3389\/fcell.2020.621578","article-title":"Identification of Key Histone Modifications and Their Regulatory Regions on Gene Expression Level Changes in Chronic Myelogenous Leukemia","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Richter, W.F., Shah, R.N., and Ruthenburg, A.J. (2021). Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia. eLife, 10.","DOI":"10.7554\/eLife.64960"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1101\/gad.323790.118","article-title":"Structural basis of recognition and destabilization of the histone H2B ubiquitinated nucleosome by the DOT1L histone H3 Lys79 methyltransferase","volume":"33","author":"Jang","year":"2019","journal-title":"Genes Dev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1073\/pnas.1317023110","article-title":"Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants","volume":"110","author":"Parker","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13073-018-0538-1","article-title":"Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing","volume":"10","author":"Li","year":"2018","journal-title":"Genome Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/bloodadvances.2018026054","article-title":"Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia","volume":"3","author":"Christiansen","year":"2019","journal-title":"Blood Adv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.267278.115","article-title":"JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev."},{"key":"ref_70","first-page":"883","article-title":"Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation","volume":"21","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molcel.2018.08.015","article-title":"Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies","volume":"72","author":"Shah","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nsmb.1714","article-title":"Structure of the MLL CXXC domain\u2013DNA complex and its functional role in MLL-AF9 leukemia","volume":"17","author":"Cierpicki","year":"2009","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:29:13Z","timestamp":1760142553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/18\/2830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":72,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["cells11182830"],"URL":"https:\/\/doi.org\/10.3390\/cells11182830","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,10]]}}}